Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00586417 · ClinicalTrials.gov registry record · NA
A Research Pilot Study in Healthy Volunteers to Evaluate Biomarkers for Novel Anticancer Treatments
A NA study, sponsored by Duke University.
- Terminated
- Registry status
- NA
- Development phase
- 61
- Enrollment target
NCT00586417 is a NA study that was terminated before completion, run by Duke University. The registered enrollment target is 61 participants.
The verdict
NCT00586417, a NA study, was terminated before completion, sponsored by Duke University.
- TERMINATED
- Registry status
- NA
- Development phase
- 61 participants
- Enrollment target
Study Summary
The overall goal of this study is to determine the feasibility and the variability of several biomarker assays in normal subjects that are relevant to tumor biology and novel anti-cancer treatments, with the goal of refining these assays for use in future therapeutic studies.
Interventions
- OTHER punch biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2007-01 |
| Est. Completion | 2012-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00586417
The ClinicalTrials.gov registry entry for NCT00586417 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which punch biopsy is the first listed.
NCT00586417 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00586417 about?
NCT00586417 is a clinical study titled "A Research Pilot Study in Healthy Volunteers to Evaluate Biomarkers for Novel Anticancer Treatments". The overall goal of this study is to determine the feasibility and the variability of several biomarker assays in normal subjects that are relevant to tumor biology and novel anti-cancer treatments, with the goal of refining these assays for use in future therapeutic studies.
What is the current status of trial NCT00586417?
This trial is currently terminated. It is a NA study. The enrollment target is 61 participants. The study started on 2007-01. Estimated completion is 2012-11.
What interventions are being tested in trial NCT00586417?
The interventions under investigation include: punch biopsy (OTHER).
Who is sponsoring clinical trial NCT00586417?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.